These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16132508)

  • 21. Ventriculolumber perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)-methyl]-1-(2-chloroethyl-1-nitrosou rea hydrochloride for subarachnoid dissemination of gliomas.
    Ushio Y; Kochi M; Kitamura I; Kuratsu J
    J Neurooncol; 1998; 38(2-3):207-12. PubMed ID: 9696373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC; Glantz MJ
    Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study.
    Lassen U; Kristjansen PE; Wagner A; Kosteljanetz M; Poulsen HS
    J Neurooncol; 1999 Jun; 43(2):161-6. PubMed ID: 10533728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas.
    Imbesi F; Marchioni E; Benericetti E; Zappoli F; Galli A; Corato M; Ceroni M
    Anticancer Res; 2006; 26(1B):553-8. PubMed ID: 16739319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.
    Brandes AA; Scelzi E; Zampieri P; Rigon A; Rotilio A; Amista P; Berti F; Fiorentino MV
    Am J Clin Oncol; 1997 Aug; 20(4):364-7. PubMed ID: 9256890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
    Beppu T; Yoshida Y; Arai H; Wada T; Suzuki M; Ogawa A; Hakozaki S; Kubo N
    J Neurooncol; 2000 Sep; 49(3):213-8. PubMed ID: 11212900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.
    Anders K; Grabenbauer GG; Schuchardt U; Fahlbusch R; Fietkau R; Sauer R; Krauseneck P
    J Neurooncol; 2000 May; 48(1):63-73. PubMed ID: 11026699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of malignant gliomas with surgery, intraarterial chemotherapy with ACNU and radiation therapy.
    Vega F; Davila L; Chatellier G; Chiras J; Fauchon F; Cornu P; Capelle L; Poisson M; Delattre JY
    J Neurooncol; 1992 Jun; 13(2):131-5. PubMed ID: 1331343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
    Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S
    Oncology; 2012; 83(1):1-9. PubMed ID: 22688083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme.
    Lassen U; Sorensen M; Gaziel TB; Hasselbalch B; Poulsen HS
    Anticancer Res; 2013 Apr; 33(4):1657-60. PubMed ID: 23564811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme.
    Fortin D; Morin PA; Belzile F; Mathieu D; Paré FM
    J Neurooncol; 2014 Sep; 119(2):397-403. PubMed ID: 24947313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
    Taal W; Oosterkamp HM; Walenkamp AM; Dubbink HJ; Beerepoot LV; Hanse MC; Buter J; Honkoop AH; Boerman D; de Vos FY; Dinjens WN; Enting RH; Taphoorn MJ; van den Berkmortel FW; Jansen RL; Brandsma D; Bromberg JE; van Heuvel I; Vernhout RM; van der Holt B; van den Bent MJ
    Lancet Oncol; 2014 Aug; 15(9):943-53. PubMed ID: 25035291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.
    Matsutani M; Nakamura O; Nakamura M; Nagashima T; Asai A; Fujimaki T; Tanaka H; Ueki K; Tanaka Y
    J Neurooncol; 1994; 19(3):227-37. PubMed ID: 7807173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic results of intra-arterial chemotherapy in patients with malignant glioma.
    Hirano Y; Mineura K; Mizoi K; Tomura N
    Int J Oncol; 1998 Sep; 13(3):537-42. PubMed ID: 9683790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
    Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy.
    Møller S; Grunnet K; Hansen S; Schultz H; Holmberg M; Sorensen M; Poulsen HS; Lassen U
    Acta Oncol; 2012 Jul; 51(6):797-804. PubMed ID: 22548369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.